Earnings History Data for Portage Biotech (PRTG) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Portage Biotech
Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-02-2024 | AH | PRTG | Portage Biotech | 11.00 | -0.18 | -0.27 | 0.00 | Portage Biotech GAAP EPS of -$1.88 misses by $1.61 [2/28/2024 5:15 PM] |
0.59 | -0.11 (-15.71%) |
0.67 | -0.03 (-4.27%) |
0.34 - 4.40 | 101,967 | 150,000 | 465 | ||
| 28-11-2023 | AH | PRTG | Portage Biotech | 27.00 | -0.29 | -0.27 | 0.00 | Portage Biotech GAAP EPS of -$0.29 [11/28/2023 4:21 PM] |
1.40 | -0.01 (-1.06%) |
0.0 | 0.0 (0.00%) |
1.21 - 7.67 | 6,986 | 30,000 | 0 | ||
| 30-08-2023 | PM | PRTG | Portage Biotech | 49.00 | -0.33 | -0.25 | 0.00 | Portage Biotech GAAP EPS of -$0.33 [8/30/2023 2:23 PM] |
2.66 | -0.41 (-13.36%) |
0.0 | 0.0 (0.00%) |
2.30 - 9.74 | 33,906 | 10,000 | 0 | ||
| 01-03-2023 | PM | PRTG | Portage Biotech | 65.00 | -0.44 | -0.23 | 0.00 | Portage Biotech GAAP EPS of -$0.44 misses by $0.21 [3/1/2023 8:59 AM] |
3.68 | -0.14 (-3.66%) |
0.0 | 0.0 (0.00%) |
3.34 - 11.99 | 11,758 | 30,000 | 0 | ||
| 01-08-2022 | PM | Before the open (Aug 1) |
PRTG | Portage Biotech | 133.00 | -0.55 | -0.34 | 0.00 | 9.87 | -0.25 (-2.47%) |
0.0 | 0.0 (0.00%) |
4.62 - 23.99 | 23,603 | 20,000 | 0 | ||
|
|
||||||||||||||||||
| 24-02-2022 | AH | PRTG | Portage Biotech | 101.00 | -0.26 | -0.28 | 0.00 | Portage Biotech GAAP EPS of -$0.26 beats by $0.01 [2/24/2022 5:49 PM] |
7.60 | -0.65 (-7.88%) |
0.0 | 0.0 (0.00%) |
6.86 - 44.98 | 23,388 | 20,000 | 0 | ||